2026年5月5日，阿尔茨海默病协会旗下期刊 Alzheimer’s & Dementia: Translational Research & Clinical Interventions 发表了 Jeffrey L. Cummings 博士团队的年度综述报告《Alzheimer’s Disease Drug Development Pipeline: 2026》。 根据报告统计，截至2026年1 ...

Veeva Systems (NYSE: VEEV) today announced Veeva Falcon, an agentic platform and standard agents for life sciences' major drug development processes. Falcon works with Veeva Development Cloud ...

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...

The American College of Clinical Pharmacology® (ACCP) published a recent Position Paper entitled "Reframing Non-Traditional PharmD Career Opportunities Across Drug Development, Regulatory, and ...

There has been much discussion recently about how artificial intelligence and machine learning (AI/ML) will revolutionize pharmaceutical research. Substantial progress has been made in the discovery ...

The Drug Discovery and Development program provides in-depth exposure to the multiple elements involved in the discovery and development of marketed drugs. It provides the rigorous scientific and ...

Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

More than 200 drugs in the pipeline for ALS are stuck in a system that favors big, slow-moving pharmaceutical companies.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug ...

Kinentia Biosciences, an East Greenbush firm that does contract drug development and manufacturing, is expanding its ...